Bank of New York Mellon »

Sarepta Therapeutics Inc Note 1.250 9/1 shares owned by Bank of New York Mellon

Quarter-by-quarter ownership of Sarepta Therapeutics Inc Note 1.250 9/1 shares owned by Bank of New York Mellon from 13F filings

Historical chart of Bank of New York Mellon investment in Sarepta Therapeutics Inc Note 1.250 9/1

Tip: Access up to 7 years of quarterly data

All positions including Sarepta Therapeutics Inc Note 1.250 9/1 held by Bank of New York Mellon consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Sarepta Therapeutics Inc Note 1.250 9/1 by Bank of New York Mellon

Quarter filed Position value Share count Share price at filing
2024-03-31 $1.1M 900k 1.17
2023-12-31 $914k 900k 1.02
2023-09-30 $1.0M 900k 1.12

More positions owned by Bank of New York Mellon

Microsoft Corporation (MSFT)
Apple (AAPL)
NVIDIA Corporation (NVDA)
Amazon (AMZN)
Meta Platforms Inc-class A Cl A (META)
Alphabet Inc-cl A Cap (GOOGL)
Alphabet Inc-cl C Cap (GOOG)
Ishares Core S&p 500 Etf Core (IVV)
JPMorgan Chase & Co. (JPM)
Berkshire Hathaway Inc-cl B CL B (BRK.B)
Eli Lilly & Co. (LLY)
Broadcom (AVGO)
Mastercard Inc - A Cl A (MA)
Exxon Mobil Corporation (XOM)
UnitedHealth (UNH)

View all positions for Bank of New York Mellon

Top funds holding Sarepta Therapeutics Inc Note 1.250 9/1

Wolverine Asset Management
Calamos Advisors
Braidwell
Davidson Kempner Capital Management
Readystate Asset Management
Bank of America Corporation
Lazard Asset Management
Tenor Capital Management
D. E. Shaw & Co
Bank Of Montreal
DZ BANK AG Deutsche Zentral Genossenschafts Bank, Frankfurt am Main
Steelhead Partners
Capstone Investment Advisors
Weiss Asset Management LP[1
CNH Partners

View all funds holding Sarepta Therapeutics Inc Note 1.250 9/1